Buchumschlag

Letter (brief communication): A pilot study of hemp hull bio gut fibre (BGF) to reduce intestinal permeability in IBS‐BAD

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Camille Lupianez‐Merly, Kara Jencks, Saam Dilmaghani, Monique Ferber, Luma Melo, B. Jan‐Willem van Klinken, Swati Kalgaonkar, Michael Camilleri
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Alimentary Pharmacology & Therapeutics
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Review article: Pharmacologic management of obesity ‐ updates on approved medications, indications and risks
von: Camille Lupianez‐Merly, et al.
Veröffentlicht: (2024)

Meta‐Analysis: Efficacy and Safety of Sequestrants for Bile Acid Diarrhoea
von: Saam Dilmaghani, et al.
Veröffentlicht: (2025)

Additional criteria on scintigraphic testing for diagnosis of rapid colonic transit in patients with chronic diarrhea
von: Camille Lupianez‐Merly, et al.
Veröffentlicht: (2024)

Editorial: Emulsifiers and thickeners in our food—Do they alter gut permeability?
von: Joshua Reid, et al.
Veröffentlicht: (2024)

Editorial: Emulsifiers and thickeners in our food—Do they alter gut permeability? Authors' reply
von: Jessica A. Fitzpatrick, et al.
Veröffentlicht: (2024)

Review: Human Intestinal Barrier—Optimal Measurement and Effects of Diet in the Absence of Overt Inflammation or Ulceration
von: Michael Camilleri
Veröffentlicht: (2025)

Letter: Interpreting Faecal SCFA Enrichment in IBS‐D—Metabolic Signal or Transit‐Related Marker?
von: Longying Zhang, et al.
Veröffentlicht: (2026)

Editorial: Food for Thought—Addressing the Nuances of Diet and Mood When Evaluating Dietary Intervention in IBS
von: Cecilia Katzenstein, et al.
Veröffentlicht: (2024)

Letter: Rifaximin Versus Low FODMAP Diet in IBS : What the Primary Endpoint Does Not Tell Us
von: Luisa Bertin, et al.
Veröffentlicht: (2026)

Editorial: Food for Thought—Addressing the Nuances of Diet and Mood When Evaluating Dietary Intervention in IBS. Authors' Reply
von: Anthony O'Connor, et al.
Veröffentlicht: (2024)

Review Article: Drug Approval for Gastroparesis—Suggestions for Improving the Process for Positive Results
von: Michael Camilleri, et al.
Veröffentlicht: (2026)

Review Article: Surrogate Endpoints to Assess Treatment Efficacy in Disorders of Gut–Brain Interaction of Lower Gastrointestinal Tract
von: Michael Camilleri, et al.
Veröffentlicht: (2025)

Review Article: The Evolving Role of GLP ‐1 Receptor Agonists in Gastroenterology Practice
von: Sydney Pomenti, et al.
Veröffentlicht: (2025)

Editorial: Disorders of gut‐brain interaction—Don't forget the older person
von: Christopher J. Black
Veröffentlicht: (2024)

Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD—Authors' reply
von: Arta Aliu, et al.
Veröffentlicht: (2024)

Review article: The role of the gut–brain axis in inflammatory bowel disease and its therapeutic implications
von: Christy Riggott, et al.
Veröffentlicht: (2024)

Editorial: Disordered eating and irritable bowel syndrome—Do maladaptive eating and weight control behaviours increase risk of a maladaptive gut?
von: Andrea Shin
Veröffentlicht: (2024)

Faecal Volatile Organic Compounds to Detect Colorectal Neoplasia in Lynch Syndrome—A Prospective Longitudinal Multicentre Study
von: Elsa L. S. A. van Liere, et al.
Veröffentlicht: (2024)

No value of non‐selective beta‐blockers after TIPS‐insertion
von: Anja Tiede, et al.
Veröffentlicht: (2024)

Editorial: The future of managing drug induced liver injury
von: Amanda Nicoll
Veröffentlicht: (2024)

Letter: Critical appraisal of biologic therapy in early ulcerative colitis management—Addressing study limitations and the role of psychological resilience—Authors' reply
von: Vibeke Strande, et al.
Veröffentlicht: (2024)

CD300A+CD8+ T Cells as Predictive Biomarkers for Achieving Functional Cure in Chronic Hepatitis B Patients Undergoing Pegylated Interferon‐Alpha Therapy
von: Peng Zhang, et al.
Veröffentlicht: (2025)

Bradycardia and Other Arrhythmias in Patients With Hepatorenal Syndrome‐Acute Kidney Injury Following Terlipressin Treatment: A Pooled Analysis of Three North American Phase III Clinical Studies
von: Jasmohan S. Bajaj, et al.
Veröffentlicht: (2025)

Research Communication: Changing Aetiology of Chronic Liver Diseases in East Asia Pacific and HCC Surveillance in Non‐Cirrhotic Patients
von: Ming Liu, et al.
Veröffentlicht: (2025)

Pain and Sedative Medication Use Among Individuals With Inflammatory Bowel Disease: A Nationwide Population‐Based Cohort Study
von: Samantha Baillie, et al.
Veröffentlicht: (2025)

Higher Prescribed Opioid Use Among Adults With Crohn's Disease Than General Population: A Nationwide Cohort Study in Sweden 2006–2021
von: Mehdi Osooli, et al.
Veröffentlicht: (2025)

Impact of non‐selective beta blockers on further decompensation and death in decompensated cirrhosis: Benefit and risk stratification by MELD score
von: Ting Wang, et al.
Veröffentlicht: (2024)

Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease‐Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute‐on‐Chronic Liver Failure and Death
von: Mathias Jachs, et al.
Veröffentlicht: (2025)

Genetic Determinants of Spontaneous Hepatitis B Surface Antigen Seroclearance and Its Associated Viral Markers
von: Jun Tao, et al.
Veröffentlicht: (2026)

Letter on ‘Non‐Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis’
von: Yi Pei, et al.
Veröffentlicht: (2025)

Letter: Are All Extra‐Digestive Cancer Signals in Inflammatory Bowel Disease Telling the Same Story?
von: Liang Jiao, et al.
Veröffentlicht: (2026)

Treatment‐Free Outcomes Following Surgery for IBD : A Nationwide Cohort Study
von: Adam S. Faye, et al.
Veröffentlicht: (2025)

Correction to ‘Stromal Vascular Fraction With Platelet‐Rich Plasma Injection During Surgery is Feasible and Safe in Treatment‐Refractory Perianal Fistulising Crohn's Disease: A Pilot Study’
Veröffentlicht: (2024)

Review Article: Extending the Frontiers of Intestinal Ultrasound Knowledge, Performance and Expansion
von: Cathy Lu, et al.
Veröffentlicht: (2025)

Meta‐Analysis: Exclusive Enteral Nutrition in Adults With Ulcerative Colitis
von: Matthew K. W. Chu, et al.
Veröffentlicht: (2025)

Racial and ethnic disparities in untreated patients with hepatitis C virus‐related hepatocellular carcinoma but not in those with sustained virologic response
von: Jung Eun Park, et al.
Veröffentlicht: (2024)

Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral‐Induced Cure of Hepatitis C Virus Infection
von: Yu‐Ping Chang, et al.
Veröffentlicht: (2025)

Issue Information
Veröffentlicht: (2026)

Editorial: New Insights Into the Aetiopathogenesis of Post‐Infective Irritable Bowel Syndrome and Functional Dyspepsia: A Significant Step Forward but What Next? Authors' Reply
von: Mohamed H. Eldesouki, et al.
Veröffentlicht: (2026)

Review Article: Targeting Peroxisome Proliferator‐Activated Receptors in Primary Biliary Cholangitis
von: Jörn M. Schattenberg, et al.
Veröffentlicht: (2026)